Advertisement
Advertisement
U.S. markets open in 3 hours 10 minutes
S&P Futures
4,327.50 +2.00 (+0.05%) Dow Futures
33,725.00 0.00 (0.00%) Nasdaq Futures
14,898.75 +32.25 (+0.22%) Russell 2000 Futures
1,799.80 +1.20 (+0.07%) Crude Oil
91.72 +0.93 (+1.02%) Gold
1,850.50 -15.60 (-0.84%)
Tandem Diabetes Care, Inc. (0M0F.L)
LSE - LSE Delayed Price. Currency in USD
Follow
As of 03:39PM BST. Market open.
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 20.82 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's Range | 0.00 - 0.00 |
| 52 Week Range | |
| Volume | |
| Avg. Volume | 317 |
| Market Cap | 11.711M |
| Beta (5Y Monthly) | 0.87 |
| PE Ratio (TTM) | 2.32 |
| EPS (TTM) | 0.09 |
| Earnings Date | Oct 31, 2023 - Nov 06, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Subscribe to Yahoo Finance Plus to view Fair Value for 0M0F.L
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
Motley Fool2 Stocks Under $25 to Buy and Hold for 10 Years
The company's current lineup includes the t:slim X2 and the newly cleared Mobi Insulin Pump, which management calls "the world's smallest durable insulin delivery system." Despite this progress on the regulatory front, Tandem has been bruised and battered on the stock market over the past year, as its financial results haven't been as good. The company's sales of insulin pumps have declined amid the challenging economy, leading to lower year-over-year revenue growth.
GuruFocus.comDecoding Tandem Diabetes Care Inc (TNDM)'s Performance Potential: A Deep Dive into Key Metrics
Unraveling the Factors That Could Limit Tandem Diabetes Care Inc's Future Growth
GuruFocus.comInvesting in Tandem Diabetes Care (TNDM): Navigating the Thin Line Between Value and Trap
An In-depth Analysis of Tandem Diabetes Care's Financial Health and Potential Risks
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
